Leukemia & Lymphoma Society of Canada
STAR RATINGCi's Star Rating is calculated based on the following independent metrics: |
✔+
FINANCIAL TRANSPARENCY
Audited financial statements for current and previous years available on the charity’s website.
B
RESULTS REPORTING
Grade based on the charity's public reporting of the work it does and the results it achieves.
n/r
DEMONSTRATED IMPACT
The demonstrated impact per dollar Ci calculates from available program information.
NEED FOR FUNDING
Charity's cash and investments (funding reserves) relative to how much it spends on programs in most recent year.
56%
CENTS TO THE CAUSE
For a dollar donated, after overhead costs of fundraising and admin/management (excluding surplus) 56 cents are available for programs.
My anchor
OVERVIEW
About Leukemia & Lymphoma Society of Canada:
Leukemia & Lymphoma Society of Canada is a 3-star charity with an average results reporting grade. It is financially transparent. Leukemia & Lymphoma Society's overhead costs of 45% are outside Ci's reasonable range for overhead spending.
Founded in 1955 in Toronto, Leukemia & Lymphoma Society of Canada (LLSC)'s mission is to support patients and their families who are living with blood cancer. There are 137 types of blood cancers and related disorders. An estimated 138,100 people in Canada are living with, or are in remission from, some form of blood cancer. LLSC achieves its mission through Public Education, Patient Support, and Research.
Public Education accounted for 45% of Leukemia & Lymphoma Society of Canada’s program spending. LLSC sponsors free community-based education programs for patients' families, caregivers and healthcare professionals. In 2020, LLSC held 23 information sessions and webcasts for healthcare professionals. 1,682 new healthcare professionals partnered with LLSC to better support people affected by blood cancer.
Patient Support accounted for 40% of program spending in F2020. LLSC offered 12 education sessions and 12 webcasts aimed to help patients make informed health decisions. In F2020, LLSC reached 2,710 new blood cancer patients and made 543 calls to vulnerable Canadians affected by blood cancer. LLSC also runs Family Support Groups that provide patients and their families with a place to share support, knowledge, and feelings. There are currently 15 groups stationed across Canada.
Research represented the final 15% of program spending in F2020. LLSC invested $668k in research in F2020. LLSC spent 84% less on Research in 2020 ($668k) compared to 2019 ($4.3m). In F2019 LLSC funded 18 new grants and supported a total of 37 grants. One of its grant programs, known as the New Idea Award, focuses on novel ideas with high potential to improve diagnosis or treatment. This program awarded five winners in 2019.
My anchor
Finances
Leukemia & Lymphoma Society of Canada has donations of $12.3m in F2020. The charity received $579k in government funding representing 4% of total revenues. Administrative costs are 14% of revenues (less investment income) and fundraising costs are 30% of donations. This results in total overhead spending of 44%. For every dollar donated, 56 cents go to the cause. This is outside of Ci’s reasonable range for overhead spending. LLSC has been outside of this range for almost every year of Ci’s analysis.
LLSC has $12.0m in funding reserves, of which $260k is donor endowed. Excluding donor-endowed funds, the charity could cover 262% or around two years and seven months of annual program costs with current reserves. Funding reserves increased 29% from 2019 due to a decrease in research grants.
This charity report is an update that has been sent to Leukemia & Lymphoma Society of Canada for review. Changes and edits may be forthcoming.
Updated on June 30, 2021 by Brenleigh Jebb.
Financial Review
Fiscal year ending June
|
2020 | 2019 | 2018 |
|---|---|---|---|
| Administrative costs as % of revenues | 14.1% | 13.5% | 13.7% |
| Fundraising costs as % of donations | 30.3% | 29.6% | 31.4% |
| Total overhead spending | 44.4% | 43.0% | 45.1% |
| Program cost coverage (%) | 261.9% | 115.3% | 54.2% |
Summary Financial StatementsAll figures in $000s |
2020 | 2019 | 2018 |
|---|---|---|---|
| Donations | 12,280 | 12,915 | 12,555 |
| Government funding | 580 | 0 | 0 |
| Investment income | 44 | 421 | 428 |
| Other income | 20 | 23 | 31 |
| Total revenues | 12,925 | 13,359 | 13,014 |
| Program costs | 4,119 | 3,686 | 3,938 |
| Grants | 368 | 4,155 | 4,664 |
| Administrative costs | 1,815 | 1,741 | 1,726 |
| Fundraising costs | 3,723 | 3,821 | 3,944 |
| Total spending | 10,025 | 13,403 | 14,273 |
| Cash flow from operations | 2,900 | (44) | (1,259) |
| Capital spending | 153 | 57 | 138 |
| Funding reserves | 11,976 | 9,283 | 4,914 |
Note: The audited financial statements report direct research expenses and allocated research expenses. Direct research expenses are reported as grants and allocated research expenses are included in program costs. The audited financial statements include direct event fundraising costs as a reduction in revenue. Ci has made adjustments to include this cost in fundraising expenses. As a result, both revenues and expenses increased by $778k in F2020, $932k in F2019, and $786k in F2018. Ci removed amortization of capital assets on a pro-rata basis from program, administrative and fundraising costs. An adjustment was made to grants reflecting the change to Grants and Fellowship payable year over year. This affected total expenses by ($131k) in F2020, $44k in F2019 and $845k in F2018.
Salary Information
$350k + |
0 |
$300k - $350k |
0 |
$250k - $300k |
0 |
$200k - $250k |
1 |
$160k - $200k |
0 |
$120k - $160k |
3 |
$80k - $120k |
6 |
$40k - $80k |
0 |
< $40k |
0 |
Information from most recent CRA Charities Directorate filings for F2020
My anchor
Comments & Contact
Comments added by the Charity:
Below are comments added by the charity for a past profile. New comments made by the charity for this updated profile may be forthcoming:
The Leukemia & Lymphoma Society of Canada (LLSC) expanded its mission in 2005 to include patient education, support and programs in addition to the research projects that had been funded since our inception in 1955. This effort, which included the addition of Social Workers and/or Oncology Nurses to support patients to our staff team, has gradually spread out across Canada and continues to grow to this present day. At the same time, it was decided that LLSC should increase its geographical reach outside of Vancouver, Calgary and Toronto so we could offer support coast-to-coast. In the last few years, we have added in stages staffed offices in Montreal, Edmonton, Saskatoon, Ottawa, Quebec City and Halifax (as of January, 2011) to meet this mandate. LLSC has also made a concerted effort to provide all materials and programming in both official languages, which were previously only available in English. These projects involve large expenditures up front, but were deemed crucial to our ability to properly meet our mission across Canada. We are proud LLSC is now truly a national organization that can help Canadians coast-to-coast through their journey with blood cancer and also give them hope for a healthy future by funding top-notch research.
Charity Contact
This email address is being protected from spambots. You need JavaScript enabled to view it. Tel: 1-833-222-4884